Insider · CIK 0001543174
Renee P Tannenbaum
Files at ANIP (ANI PHARMACEUTICALS INC), CRDF (Cardiff Oncology, Inc.). First filing Dec 16, 2024, latest Dec 9, 2025.
Renee P Tannenbaum files SEC Form 4 as director at ANIP (ANI PHARMACEUTICALS INC), and also at CRDF (Cardiff Oncology, Inc.). Since Dec 16, 2024, Renee P Tannenbaum has reported 1 open-market buy worth $34k and 1 open-market sell worth $146k, the latest filed on Dec 9, 2025.
A track record needs three past buys with six months of prices behind them; Renee P Tannenbaum has 0, so none is measured yet.
The newest scored trade: sold $146k of ANIP on Dec 5, 2025, filed Dec 9, 2025, scored 41 (moderate). In the last 12 months: 0 buys worth $0 and 1 sell worth $146k.
Where the trades landed
Last year at the 2 companies this insider has traded most, with each buy and sell on the bar it happened.
ANIP: ANI PHARMACEUTICALS INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
CRDF: Cardiff Oncology, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 41Moderate | ANI PHARMACEUTICALS INC | $146k 1,800 shares | -7% | +53% from low-17% from high | |
| 46Moderate | Cardiff Oncology, Inc. | $34k 10,000 shares | +100% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Dec 9, 2025 | ANIP ANI Pharmaceuticals, Inc. | 1,800 0.01% of outstanding | $146k | Dec 5, 2025 | none |
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 11, 2026 | CRDF Cardiff Oncology, Inc. | AGrant or award Stock Optionsderivative | +40,565 | $0.00 | $0 | 209,331 | Jun 15, 2026 |
| May 21, 2026 | ANIP ANI PHARMACEUTICALS INC | AGrant or award Common Stock | +4,357 | $0.00 | $0 | 29,514 | Jun 10, 2026 |
| Dec 5, 2025 | ANIP ANI PHARMACEUTICALS INC | SOpen-market sale Common Stock | -1,800 | $81.15 | $146k | 25,157 | Dec 9, 2025 |
| Jun 26, 2025 | CRDF Cardiff Oncology, Inc. | AGrant or award Stock Optionsderivative | +40,565 | $0.00 | $0 | 168,766 | Jun 30, 2025 |
| May 22, 2025 | ANIP ANI PHARMACEUTICALS INC | AGrant or award Common Stock | +4,336 | $0.00 | $0 | 26,957 | May 27, 2025 |
| Dec 12, 2024 | CRDF Cardiff Oncology, Inc. | POpen-market purchase Common Stock | +10,000 | $3.42 | $34k | 20,000 | Dec 16, 2024 |
Questions about Renee P Tannenbaum
Answered from the filings on this page, as of the latest one.
Is Renee P Tannenbaum buying or selling?
In the last 12 months Renee P Tannenbaum reported 0 open-market buys worth $0 and 1 open-market sell worth $146k on SEC Form 4; the latest was sold $146k of ANIP on Dec 5, 2025. Grants, option exercises and tax withholding are not counted.
How did Renee P Tannenbaum's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Renee P Tannenbaum has 0.
Where does Renee P Tannenbaum file Form 4?
Renee P Tannenbaum has filed Form 4 at ANIP (ANI PHARMACEUTICALS INC); CRDF (Cardiff Oncology, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.